1
|
Solloch UV, Giani AS, Pattillo Garnham MI, Sauter J, Bernas SN, Lange V, Barriga F, Fernández-Viña MA, Schmidt AH. HLA allele and haplotype frequencies of registered stem cell donors in Chile. Front Immunol 2023; 14:1175135. [PMID: 37313414 PMCID: PMC10258311 DOI: 10.3389/fimmu.2023.1175135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2023] [Accepted: 05/15/2023] [Indexed: 06/15/2023] Open
Abstract
Patients in need of hematopoietic stem cell transplantation often rely on unrelated stem cell donors matched in certain human leukocyte antigen (HLA) genes. Donor search is complicated by the extensive allelic variability of the HLA system. Therefore, large registries of potential donors are maintained in many countries worldwide. Population-specific HLA characteristics determine the registry benefits for patients and also the need for further regional donor recruitment. In this work, we analyzed HLA allele and haplotype frequencies of donors of DKMS Chile, the first Chilean donor registry, with self-assessed "non-Indigenous" (n=92,788) and "Mapuche" (n=1,993) ancestry. We identified HLA alleles that were distinctly more abundant in the Chilean subpopulations than in worldwide reference populations, four of them particularly characteristic for the Mapuche subpopulation, namely B*39:09g, B*35:09, DRB1*04:07g, and DRB1*16:02g. Both population subsamples carried haplotypes of both Native American and European origin at high frequencies, reflecting Chile's complex history of admixture and immigration. Matching probability analysis revealed limited benefits for Chilean patients (both non-Indigenous and Mapuche) from donor registries of non-Chilean donors, thus indicating a need for ongoing significant donor recruitment efforts in Chile.
Collapse
|
2
|
Schor D, Porto LC, Roma EH, Castro-Alves J, Villela AP, Araújo AQC, Glória Bonecini-Almeida M. Putative role of HLA polymorphism among a Brazilian HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) population. Sci Rep 2023; 13:7659. [PMID: 37169817 PMCID: PMC10173239 DOI: 10.1038/s41598-023-34757-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2022] [Accepted: 05/06/2023] [Indexed: 05/13/2023] Open
Abstract
Around ten million people are infected with HTLV-1 worldwide, and 1-4% develop HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), characterized by an important degeneration of the spinal cord, which can lead to death. Distinct HLA alleles have been associated with either HAM/TSP susceptibility or protection. However, these HLA alleles set may change according to the population studied. Brazil is the second country in the number of HTLV-1-infected people and there are few reports addressing the HLA influence on HTLV-1 infection as well as on disease outcome. The objective of this study was to evaluate the influence of HLA alleles as a risk factor for HAM/TSP and the proviral load (PVL) levels, clinical progression, and death outcomes in an admixed Brazilian population. The HLA-A, -B, -C, and -DRB1 were genotyped in 375 unrelated HTLV-1-infected individuals divided into asymptomatic carriers (AC) (n = 165) and HAM/TSP (n = 210) in a longitudinal cohort from 8 to 22 years of follow-up. Because locus B deviated from Hardy-Weinberg Equilibrium for the study groups, the results represented for HLA-B alleles were inconclusive. The alleles HLA-A*68 and -C*07 were related to HAM/TSP risk in multivariate analysis. The alleles HLA-A*33, and -A*36 were associated with protection against disease progression in HAM/TSP patients, while -C*12, -C*14, and -DRB1*08 were associated with increased risk of death. In the AC group, the presence of, -C*06 and -DRB1*15 alleles influenced an increased PVL, in an adjusted linear regression model, while -A*30, -A*34, -C*06, -C*17 and -DRB1*09 alleles were associated with increased PVL in HAM/TSP group compared to HAM/TSP individuals not carrying these alleles. All these alleles were also related to increased PVL associated with clinical progression outcome. Increased PVL associated with the death outcome was linked to the presence of HLA-A*30. PVL has been associated with HLA, and several alleles were related in AC and HAM/TSP patients with or without interacting with clinical progression outcomes. Understanding the prognostic value of HLA in HAM/TSP pathogenesis can provide important biomarkers tools to improve clinical management and contribute to the discovery of new therapeutic interventions.
Collapse
Affiliation(s)
- Doris Schor
- Laboratório de Imunologia e Imunogenética em Doenças Infecciosas, Instituto Nacional de Infectologia Evandro Chagas-INI/FIOCRUZ, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, 21040-900, Brazil
| | - Luís Cristóvão Porto
- Laboratório de Histocompatibilidade e Criopreservação, Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, RJ, 20950-000, Brazil
| | - Eric Henrique Roma
- Laboratório de Imunologia e Imunogenética em Doenças Infecciosas, Instituto Nacional de Infectologia Evandro Chagas-INI/FIOCRUZ, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, 21040-900, Brazil.
| | - Julio Castro-Alves
- Plataforma de Pesquisa Clínica, Instituto Nacional de Infectologia Evandro Chagas-INI/FIOCRUZ, Rio de Janeiro, RJ, 21040-900, Brazil
| | - Anna Paula Villela
- Laboratório de Histocompatibilidade e Criopreservação, Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, RJ, 20950-000, Brazil
| | - Abelardo Q C Araújo
- Laboratório de Pesquisa Clínica em Neuroinfecções, Instituto Nacional de Infectologia Evandro Chagas-INI/FIOCRUZ, Rio de Janeiro, RJ, 21040-900, Brazil
| | - Maria Glória Bonecini-Almeida
- Laboratório de Imunologia e Imunogenética em Doenças Infecciosas, Instituto Nacional de Infectologia Evandro Chagas-INI/FIOCRUZ, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, 21040-900, Brazil
| |
Collapse
|
3
|
Escobar-Castro K, Hernández-Zaragoza DI, Santizo A, Del Toro-Arreola S, Hernández E, Toledo S M. HLA molecular study of patients in a public kidney transplant program in Guatemala. Hum Immunol 2022; 83:741-748. [PMID: 36028459 DOI: 10.1016/j.humimm.2022.08.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2021] [Revised: 07/31/2022] [Accepted: 08/02/2022] [Indexed: 11/28/2022]
Abstract
Guatemala is a country located in Central America, and while it is one of the most populated countries in the region, the genetic diversity of the population has been poorly analyzed. Currently, there are no analyses of the distribution of human leukocyte antigen (HLA) system alleles in mixed ancestry (i.e., ladino) populations in Guatemala. The HLA system exhibits the most extensive polymorphism in the human genome and has been extensively analyzed in a large number of studies related to disease association, transplantation, and population genetics (with particular importance in the understanding of diversity in the human population). Here, we present HLA typing data from 127 samples of unrelated individuals from the kidney transplant program of the San Juan de Dios General Hospital (Guatemala City) using a PCR-SSOP-based (PCR-sequence specific oligonucleotide probes) typing method. We found 16 haplotypes that accounted for 39.76 % of the total haplotype diversity, of which thirteen have been reported previously in Native American populations and three have been reported in European populations. The analyses showed no deviations from Hardy-Weinberg equilibrium, and admixture estimates calculated with k = 3 ancestral components showed that Native American was the most represented component, followed by the European component. The African component was less prominent in the Guatemala mixed ancestry sample in comparison to samples from other countries in Central America. The HLA-based admixture results for Central America showed a continuum in the distribution of Native American, European and African ancestries throughout the region, which is consistent with the complex demographic history of the region.
Collapse
Affiliation(s)
- Karla Escobar-Castro
- Escuela de Estudios de Postgrado, Facultad de Ciencias Médicas, Universidad de San Carlos de Guatemala (USAC), Guatemala City, Guatemala; Laboratorio de Histocompatibilidad, Departamento de Nefrología y Trasplante, Hospital General San Juan de Dios, Guatemala City, Guatemala
| | - Diana Iraiz Hernández-Zaragoza
- Laboratorio de Genética Molecular, Escuela Nacional de Antropología e Historia (ENAH), Mexico City, Mexico; Unidad de Inmunogenética, Técnicas Genéticas Aplicadas a la Clínica (TGAC), Mexico City, Mexico.
| | - Adolfo Santizo
- Laboratorio de Histocompatibilidad, Departamento de Nefrología y Trasplante, Hospital General San Juan de Dios, Guatemala City, Guatemala
| | - Susana Del Toro-Arreola
- Instituto de Investigación en Enfermedades Crónico-Degenerativas, Centro Universitario en Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico
| | - Elisa Hernández
- Laboratorio de Histocompatibilidad, Departamento de Nefrología y Trasplante, Hospital General San Juan de Dios, Guatemala City, Guatemala
| | - Manuel Toledo S
- Departamento de Nefrología y Trasplante, Hospital General San Juan de Dios, Guatemala City, Guatemala
| |
Collapse
|
4
|
Hernández-Doño S, Sánchez-González RA, Trujillo-Vizuet MG, Zamudio-Castellanos FY, García-Silva R, Bulos-Rodríguez P, Vazquez-Guzmán CA, Cárdenas-Ramos X, de León Rodríguez D, Elías F, Domínguez-Arevillaga S, Pérez-Tirado JM, Vera-Lastra OL, Granados J, Sepúlveda-Delgado J. Protective HLA alleles against severe COVID-19: HLA-A*68 as an ancestral protection allele in Tapachula-Chiapas, Mexico. Clin Immunol 2022; 238:108990. [PMID: 35395388 PMCID: PMC8982524 DOI: 10.1016/j.clim.2022.108990] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2021] [Revised: 02/13/2022] [Accepted: 03/25/2022] [Indexed: 11/03/2022]
Abstract
HLA is a polymorphic antigen presenter which has provided valuable information on the susceptibility of populations to viruses. Therefore, the study of HLA can reveal specific susceptibility or resistance alleles to severe COVID-19 in an ethnically dependent manner. This pilot study investigated HLA alleles associated with COVID-19 severity in Tapachula, Chiapas, Mexico. A total of 146 Mexican Mestizos were typed for HLA class I and II using PCR-SSP. The patients were classified according to the outcome (death or improvement) and the infection's severity (mild or severe). In addition, a group of exposed uninfected individuals was included. HLA-A*68 was found to be a protective allele against the severe infection and fatal outcome; pC = 0.03, OR = 0.4, 95% CI =0.20-0.86, and pC =0.009, OR = 0.3, 95% CI =0.13-0.71 respectively. HLA-DRB1*03 also appears to be a protective factor against fatal outcome pC = 0.009, OR = 0.1, 95%IC = 0.01-0.66; however, the low frequency of this allele in the studied population limits the statistical power. The severity and fatal outcome of COVID-19 patients in Tapachula, Chiapas depend more on the lack of resistance than susceptibility HLA alleles.
Collapse
Affiliation(s)
- Susana Hernández-Doño
- Department of Transplantation, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
| | | | | | | | - Rafael García-Silva
- Department of Transplantation, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
| | - Pedro Bulos-Rodríguez
- Department of Internal Medicine, Hospital Regional de Alta Especialidad Ciudad Salud, Tapachula, Chiapas, Mexico
| | - Carlos A Vazquez-Guzmán
- Department of Internal Medicine, Hospital Regional de Alta Especialidad Ciudad Salud, Tapachula, Chiapas, Mexico
| | | | - Diana de León Rodríguez
- Facultad de Medicina Humana Campus IV, Universidad Autónoma de Chiapas, Mexico; Becario de la Dirección General de Calidad y Educación en Salud, Secretaría de Salud, Mexico
| | - Fabiola Elías
- Facultad de Medicina Humana Campus IV, Universidad Autónoma de Chiapas, Mexico
| | | | | | - Olga Lidia Vera-Lastra
- Department of Internal Medicine, Hospital de Especialidades, Centro Médico la Raza, Chile
| | - Julio Granados
- Department of Transplantation, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
| | - Jesús Sepúlveda-Delgado
- Research Division, Hospital Regional de Alta Especialidad Ciudad Salud, Tapachula, Chiapas, Mexico.
| |
Collapse
|
5
|
Ibáñez S, Valenzuela O. Spondyloarthritis in Chile: Challenges and Opportunities. J Clin Rheumatol 2021; 27:e134-e136. [PMID: 30059415 DOI: 10.1097/rhu.0000000000000886] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Affiliation(s)
- Sebastián Ibáñez
- Facultad de Medicina Clínica Alemana-Universidad del Desarrollo Santiago, Chile Padre Hurtado Hospital San Ramón, Chile
| | | |
Collapse
|
6
|
Costa J, Lima N, Santos C. An overview on possible links between aflatoxin B 1 exposure and gallbladder cancer. Mycotoxin Res 2021; 37:205-214. [PMID: 34019215 DOI: 10.1007/s12550-021-00431-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2020] [Revised: 03/26/2021] [Accepted: 05/12/2021] [Indexed: 12/13/2022]
Abstract
Gallbladder cancer (GBC) is one of the most common sites for biliary tract cancers. It has a worldwide distribution being endemic in South America and Southern Asia. These high GBC rates have previously been linked to the determinants of health such as nutrition, genetics, lifestyle, and environment. Exposure to aflatoxin B1 (AFB1), a human carcinogen, is suggested to be involved with GBC development. This work aims to analyse the interplay of social, lifestyle, and genetic predisposing factors to GBC. AFB1 plays a pivotal role in carcinogenic onset by genetic and epigenetic modifications. AFB1 can induce molecular changes involved in the GBC pathogenesis, such as overexpression of UCHL1 gene, mutagenesis of TP53 gene, abnormal expression of oncogenes BCL-2, and aberrantly methylation of ERBB family receptors. However, a large-scale scientific cooperation is needed to confirm these molecular links through which AFB1 may increase the GBC risk. For that, monitoring AFB1 exposure through AF-albumin and AFB1-lysine will clarify the level of exposure of the population to AFB1 in the GBC hotspot. Further, analyses of AFB1-adduct concentrations in GBC cases (fatal and non-fatal) are needed to understanding if AF contamination can trigger gallbladder cancer.
Collapse
Affiliation(s)
- Jéssica Costa
- Programa de Doctorado en Ciencias de Recursos Naturales, Universidad de La Frontera, 4811-230, Temuco, Chile
| | - Nelson Lima
- CEB-Biological Engineering Centre, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal
| | - Cledir Santos
- Department of Chemical Science and Natural Resources, Universidad de La Frontera, 4811-230, Temuco, Chile.
| |
Collapse
|
7
|
Castro-Santos P, Olloquequi J, Verdugo RA, Gutiérrez MA, Pinochet C, Quiñones LA, Díaz-Peña R. HLA-DRB1*07:01 and * 08:02 Alleles Confer a Protective Effect Against ACPA-Positive Rheumatoid Arthritis in a Latin American Admixed Population. BIOLOGY 2020; 9:biology9120467. [PMID: 33327594 PMCID: PMC7765073 DOI: 10.3390/biology9120467] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/09/2020] [Revised: 12/11/2020] [Accepted: 12/13/2020] [Indexed: 06/12/2023]
Abstract
HLA-DRB1 shared epitope (SE) alleles are important genetic contributors for the risk of developing anti-citrullinated protein antibodies (ACPA)-positive rheumatoid arthritis (RA), particularly in Caucasians. We aimed to analyze the contribution of HLA-DRB1 alleles and single nucleotide polymorphisms (SNPs) within the major histocompatibility complex (MHC) region to the susceptibility to develop ACPA-positive RA in a Latin American (LA) population with admixed ancestry. A total of 289 ACPA-positive RA patients and 510 controls were enrolled in this study. The presence of HLA-DRB1*04:01, *09:01 and *10:01 was increased in ACPA-positive RA patients compared with healthy controls (p < 0.0001, p < 0.001 and p < 0.01, respectively), whereas DRB1*07:01 and *08:02 was associated with a decreased risk of ACPA-positive RA (p < 0.001 and p < 0.01, respectively). These results showed a strong correlation with estimates from studies in Asians but not in Caucasian populations. The present study describes the protective effects of the HLA-DRB1*07:01 and *08:02 alleles in ACPA-positive RA patients in a LA population for the first time. Identifying relationships between HLA-DRB1 alleles and RA is important for identifying disease associations in different ethnic groups in order to reach a better understanding of RA worldwide.
Collapse
Affiliation(s)
- Patricia Castro-Santos
- Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Talca 3460000, Chile; (P.C.-S.); (J.O.)
- Inmunología, Centro de Investigaciones Biomédicas (CINBIO), Universidad de Vigo, 36310 Vigo, Spain
| | - Jordi Olloquequi
- Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Talca 3460000, Chile; (P.C.-S.); (J.O.)
| | - Ricardo A. Verdugo
- Programa de Genética Humana, ICBM, Facultad de Medicina, Universidad de Chile, Santiago 8389100, Chile;
- Departamento de Oncología Básico-Clínico, Facultad de Medicina, Universidad de Chile, Santiago 8389100, Chile
| | - Miguel A. Gutiérrez
- Rheumatology, Almirante Nef Naval Hospital, Viña del Mar, Valparaíso 2340000, Chile;
- School of Medicine, Valparaíso University, Valparaíso 2340000, Chile
| | | | - Luis A. Quiñones
- Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology, Faculty of Medicine, University of Chile, Santiago 8320000, Chile
- Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), 28015 Madrid, Spain
| | - Roberto Díaz-Peña
- Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Talca 3460000, Chile; (P.C.-S.); (J.O.)
| |
Collapse
|
8
|
Arnaiz-Villena A, Juarez I, Crespo-Yuste E, Lopez-Nares A, Callado A, Vargas-Alarcon G, Vaquero C, Suarez-Trujillo F. Study of HLA genes in Mexico Mayo/Yoremes Amerindians: Further support of gene exchange with Pacific Islanders. Hum Immunol 2020; 81:195-196. [DOI: 10.1016/j.humimm.2020.02.012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2020] [Revised: 02/27/2020] [Accepted: 02/27/2020] [Indexed: 11/26/2022]
|
9
|
Castro‐Santos P, Olloquequi J, Díaz‐Peña R. HLA‐A, B, C and DRB1 alleles in a Chilean population from Talca. HLA 2020; 95:200-203. [DOI: 10.1111/tan.13775] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2019] [Revised: 12/11/2019] [Accepted: 12/12/2019] [Indexed: 11/26/2022]
Affiliation(s)
| | - Jordi Olloquequi
- Facultad de Ciencias de la SaludUniversidad Autónoma de Chile Talca Chile
| | - Roberto Díaz‐Peña
- Facultad de Ciencias de la SaludUniversidad Autónoma de Chile Talca Chile
| |
Collapse
|
10
|
Arnaiz-Villena A, Juarez I, Lopez-Nares A, Palacio-Grüber J, Vaquero C, Callado A, H-Sevilla A, Rey D, Martin-Villa JM. Frequencies and significance of HLA genes in Amerindians from Chile Cañete Mapuche. Hum Immunol 2019; 80:419-420. [PMID: 31101374 DOI: 10.1016/j.humimm.2019.04.015] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2019] [Revised: 04/22/2019] [Accepted: 04/23/2019] [Indexed: 11/26/2022]
Abstract
Mapuche Amerindians live now widespread in Central South Chile and Argentina and speak "Mapudungun", an unclassified language. A group of Chilean Mapuche was studied for HLA genes using standard techniques. Typical Amerindian HLA genes and haplotypes are found in the population, like HLA-DRB1*14:02, -08:02 and class II haplotype DRB1*08:02-DQB1*04:02. However, these and other genes are also common in Pacific Islanders. Thus, relatedness of First America Inhabitants with some Pacific Islanders is stressed. Evidences of Pacific and Atlantic cultural and genetic exchange, probably in both directions, and California Man settlements found since 130,000 years ago makes it necessary a revision of Americas peopling. This study may be also useful for medical Mapuche use in Transplantation and HLA and disease Epidemiology.
Collapse
Affiliation(s)
- Antonio Arnaiz-Villena
- Department of Immunology, University Complutense, School of Medicine, The Madrid Regional Blood Center, 28040 Madrid, Spain.
| | - Ignacio Juarez
- Department of Immunology, University Complutense, School of Medicine, The Madrid Regional Blood Center, 28040 Madrid, Spain
| | - Adrian Lopez-Nares
- Department of Immunology, University Complutense, School of Medicine, The Madrid Regional Blood Center, 28040 Madrid, Spain
| | - José Palacio-Grüber
- Department of Immunology, University Complutense, School of Medicine, The Madrid Regional Blood Center, 28040 Madrid, Spain
| | - Christian Vaquero
- Department of Immunology, University Complutense, School of Medicine, The Madrid Regional Blood Center, 28040 Madrid, Spain
| | - Alvaro Callado
- Department of Immunology, University Complutense, School of Medicine, The Madrid Regional Blood Center, 28040 Madrid, Spain
| | - Alejandro H-Sevilla
- Department of Immunology, University Complutense, School of Medicine, The Madrid Regional Blood Center, 28040 Madrid, Spain
| | - Diego Rey
- Department of Immunology, University Complutense, School of Medicine, The Madrid Regional Blood Center, 28040 Madrid, Spain
| | - José Manuel Martin-Villa
- Department of Immunology, University Complutense, School of Medicine, The Madrid Regional Blood Center, 28040 Madrid, Spain
| |
Collapse
|
11
|
Galarza JM, Barquera R, Álvarez AMT, Hernández Zaragoza DI, Sevilla GP, Tamayo A, Pérez M, Dávila D, Birnberg L, Alonzo VA, Krause J, Grijalva M. Genetic diversity of the HLA system in human populations from the Sierra (Andean), Oriente (Amazonian) and Costa (Coastal) regions of Ecuador. Hum Immunol 2018; 79:639-650. [DOI: 10.1016/j.humimm.2018.06.004] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2018] [Revised: 05/23/2018] [Accepted: 06/07/2018] [Indexed: 12/13/2022]
|
12
|
Mardones F, Valenzuela Y, Zemelman V. Analysis of androgenetic alopecia in Amerindian people (Mapuche) from southern Chile. Int J Dermatol 2017; 55:e595-e596. [PMID: 27459731 DOI: 10.1111/ijd.13051] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/08/2014] [Revised: 03/21/2015] [Accepted: 04/01/2015] [Indexed: 11/30/2022]
Affiliation(s)
- Felipe Mardones
- Department of Dermatology, University of Chile Clinical Hospital, Santiago, Chile.
| | - Yesenia Valenzuela
- Department of Dermatology, University of Chile Clinical Hospital, Santiago, Chile
| | - Viviana Zemelman
- Department of Dermatology, University of Chile Clinical Hospital, Santiago, Chile
| |
Collapse
|
13
|
Arnaiz-Villena A, Muñiz E, del Palacio-Gruber J, Campos C, Alonso-Rubio J, Gomez-Casado E, Lopez-Pacheco F, Martin-Villa M, Silvera C. Ancestry of Amerindians and its Impact in Anthropology, Transplantation, HLA Pharmacogenomics and Epidemiology by HLA Study in Wiwa Colombian Population. ACTA ACUST UNITED AC 2016. [DOI: 10.2174/1874220301603010269] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Background:HLA autosomic genes are unique because they conform the most polymorphic human system. Importance of this system is recognized in Medicine for Transplantation, Epidemiology (HLA and disease linkage), Pharmacogenomics (HLA linked to drug side effects) and for defining the origin of populations in both male and female lineages.Objectives:Studying HLA profile of a isolated Amerindian group from North Colombia (Wiwa) in order to draw conclusions about its Preventive Medicine, the genetic relationship with Worldwide populations and America peopling, since this last issue is hotly debated.Methodology:A total of 14,660 HLA chromosomes were included. Peripheral blood was obtained from volunteer blood donors belonging to Wiwa (also named Arsario) ethnic group. HLA-A, -B, -C, -DRB1 and -DQB1 genes were analyzed by standard methods. Wiwa Amerindians relationships with others were calculated by using Arlequin, Dispan and Vista software computer packages.Results:Extended HLA, -A, -B, -C, -DRB1 and -DQB1 haplotypes have been studied for the first time in this population. Classical Amerindian haplotypes have been found and also new Wiwa (Arsario) Amerindian haplotypes. New haplotypes are A*68:01 - B*15:01 - C*03:03 - DRB1*14:02 - DQB1*03:02, A*11:01 - B*07:02 - C*07:02 - DRB1*15:03 - DQB1*06:02 and A*68:01 - B*15:01 - C*03:04 - DRB1*14:02 - DQB1*03:01.Conclusion:They have been reached after exhaustive comparisons of Wiwa with other Amerindians and Worldwide populations by using genetic distances, Neighbor Joining trees, correspondence analysis and specific group of alleles which are common and frequent in both Amerindians and Pacific Islanders. They are: 1) The Americas First Inhabitants have been probably come through Bering Strait and also through Pacific (from Austronesia and Asia) and Atlantic (from Europe) routes. A bidirectional gene flow is not discarded. 2) Genetic HLA Amerindian profile is separated from that of other Worldwide populations. 3) Amerindians geographical proximity groups’ relatedness is not concordant with HLA genetic relatedness, neither with language. This may be explained by a substantial population decrease that occurred after Europeans invaded America in 1492 and carried new pathogens and epidemics. 4) Our results are also useful for Wiwa and other Amerindians future preventive medicine (HLA linked diseases), HLA pharmacogenomics and transplantation regional programs.
Collapse
|
14
|
Céspedes-Garro C, Naranjo MEG, Ramírez R, Serrano V, Fariñas H, Barrantes R, LLerena A. Pharmacogenetics in Central American healthy volunteers: interethnic variability. Drug Metab Pers Ther 2015; 30:19-31. [PMID: 25490028 DOI: 10.1515/dmdi-2014-0025] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2014] [Accepted: 11/05/2014] [Indexed: 12/12/2022]
Abstract
Ethnicity is one of the major factors involved in interindividual variability to drug response. This study aims to describe the frequency of the most relevant pharmacogenetic biomarkers and metabolic phenotypes in Central American healthy volunteers and to determine its interethnic variability. Twenty-six original research articles on allelic, genotypes or metabolic phenotype frequencies were analyzed, in which a total number of 7611 Central American healthy volunteers were included (6118 were analyzed for genotype and 1799 for metabolic phenotype). No reports were available for population from Belize and Honduras. The CYP2D6*4 and *5 frequencies in Amerindian populations from Costa Rica have shown to be among the highest frequencies so far reported in the world. Furthermore, NAT2*5 and *6 presented higher frequencies in admixed populations than in Amerindians, but, inversely, the NAT2*7 was more frequent in Amerindians compared to an admixed population. Likewise, different patterns of distribution have been shown in HLA-A*02, *03 and HLA-B*07 among Native populations from Latin America. Reports on Central American populations were also found for the CYP2C19, LDLR, CYP2E1, MDR1, G6PD, TP53, CYP1A2, CYP3A4 and CYP3A5 biomarkers, but no data were available for the other 91 pharmacogenetic biomarkers revised in Central American populations. Differences in the frequency of some pharmacogenetic biomarkers and metabolic phenotypes were found, showing interethnic variability within Central American and with other Latin American populations.
Collapse
|
15
|
Arnaiz-Villena A, Vargas-Alarcón G, Areces C, Enríquez-de-Salamanca M, Abd-El-Fatah-Khalil S, Fernández-Honrado M, Marco J, Martín-Villa JM, Rey D. Mixtec Mexican Amerindians: an HLA Alleles Study for America Peopling, Pharmacogenomics and Transplantation. Immunol Invest 2014; 43:738-55. [PMID: 25254939 DOI: 10.3109/08820139.2014.926369] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|